Based on the original module, Perioperative Cardiac Risk Management, by Zishan Siddiqui, MD, and Leonard Feldman, MD, FACP, SFHM
Perioperative cardiac complications are the most widely feared medical issues for the anesthesiologist, surgeon, and medical consultant as they approach a patient with the option of surgery. To assess for the preoperative cardiac risk, hospitalists should follow a step-wise algorithm. The following module reviews the risk assessment process and enables the hospitalist to order appropriate preoperative testing.
Provide hospitalists with current assessment strategies to evaluate for perioperative cardiac risk.
This activity is designed for hospitalists.
After completing the module, the participant will demonstrate the ability to:
- Tailor the perioperative evaluation based on the urgency of the procedure.
- Determine if there are red flag issues that may necessitate delaying nonemergent surgery.
- Estimate the combined clinical/surgical risk based on validated models.
- Determine functional status using metabolic equivalents.
- Assess the appropriate uses for cardiac stress testing and coronary revascularization.
- Evaluate the role of perioperative biomarkers for cardiac risk assessment.
This activity currently does not have any CME available. The series SHM Consults is reviewing all content and will publish an accredited module based on this topic when available.
Estimated time to complete activity: 2 hours
FACULTY AND FACULTY DISCLOSURES
The following relationships have been reported for this activity:
Leonard Feldman, MD (Chair)
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Med-Peds Urban Health Residency Program Director
Associate Program Director, Osler Medical Residency
Director, Comprehensive General Medicine Consult Service
Editor, Consultative, and Perioperative Medicine Essentials for Hospitalists
Dr Feldman reports having no relevant financial or advisory relationships with corporate organizations related to this activity.
Steven L. Cohn, MD, FACP, SFHM
Medical Director – UHealth Preoperative Assessment Center
Director – Medical Consultation Service
Professor of Clinical Medicine
University of Miami Miller School of Medicine
Dr Cohn reports owning stock in AstraZeneca, GlaxoSmithKline, Merck & Co, Inc, and Pfizer Inc; and reports serving on the advisory committee/board for Bristol-Myers Squibb Company and Janssen.
Bartho Caponi, MD (Peer Reviewer)
Clinical Assistant Professor
Division of Hospital Medicine
University of Wisconsin Hospital and Clinics
Dr Caponi reports having no relevant financial or advisory relationships with corporate
organizations related to this activity.
SHM CONFLICT OF INTEREST DISCLOSURE POLICY
In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.
Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.
to download the references for this educational activity.
The following is an interactive educational module designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-test, a study program, and an unaccredited post-test.